Best Protease Inhibitor for acquired immunodeficiency syndrome
Top-rated pick: Reyataz — pharmaranks score 72/100, the highest of the 2 Protease Inhibitor drugs used for acquired immunodeficiency syndrome, ranked by our independent FDA recall-safety score. Compare them with all treatments for acquired immunodeficiency syndrome or the full Protease Inhibitor class. Not medical advice — always consult a professional.
Quick answer: Of the 2 protease inhibitor drugs we rate for acquired immunodeficiency syndrome, all are available as lower-cost generics, and most are capsule. Our ranking reflects each drug’s FDA recall-safety record — not clinical effectiveness for acquired immunodeficiency syndrome; the right choice depends on your situation, so confirm it with your prescriber.
Other drug classes for acquired immunodeficiency syndrome
Top protease inhibitor for acquired immunodeficiency syndrome: 1. Reyataz · 2. Prezista
| # | Drug | Rating | Type | Form | Generic? | Pharmacy pays | |
|---|---|---|---|---|---|---|---|
| 1 | 72/100 | Prescription | Capsule | Generic | $53 | View → | |
| 2 | Not yet rated | Prescription | Suspension | Generic | $50 | View → |
Full ranking · 2 drugs
reyataz
PrescriptionFDA-sourced
Reyataz (Atazanavir Sulfate) is a protease inhibitor used to treat Acquired Immunodeficiency Syndrome.
Pharmacy pays
From ~$32.65/30· 2 forms Save up to 6% in classprezista
PrescriptionFDA-sourced
Prezista (Darunavir) is a protease inhibitor used to treat Acquired Immunodeficiency Syndrome, Hiv Infections.
Pharmacy pays
From ~$34.47/30· 2 formsFrequently asked
- What is the best protease inhibitor for acquired immunodeficiency syndrome?
- By our independent recall-safety rating — not an efficacy measure — reyataz ranks highest among Protease Inhibitor drugs used for acquired immunodeficiency syndrome. Always consult a professional.
- Which protease inhibitor drugs treat acquired immunodeficiency syndrome?
- pharmaranks lists 2 Protease Inhibitor products used for acquired immunodeficiency syndrome, per NIH RxClass drug-classification data — each independently rated and ranked above.
- How are these ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.